schizophrenia

Oct 15 2026

Uncategorized

FDA Approves Once-Monthly Injectable Olanzapine for Adults With Schizophrenia

by Clinical Editor

No Comments

The US FDA has approved Weltruza (olanzapine extended-release injectable suspension), a once-monthly subcutaneous formulation for treating schizophrenia in adults. The formulation offers a …

Oct 15 2026

Uncategorized

Scientists may have overlooked a hidden Alzheimer’s culprit for decades

by Clinical Editor

No Comments

For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results. Now, researchers at...

Oct 14 2026

Uncategorized

Formulations Matter: The Approval of Olanzapine Extended-Release Injectable Suspension for Schizophrenia – Psychiatric Times

by Clinical Editor

No Comments

Formulations Matter: The Approval of Olanzapine Extended-Release Injectable Suspension for Schizophrenia  Psychiatric Times

Oct 13 2026

Uncategorized

Tortugas’ schizophrenia drug proves worth in phase 2 Hansoh trial in China

by Clinical Editor

No Comments

Tortugas Neuroscience’s schizophrenia drug from Hansoh Pharma has proven its worth in a phase 2b study, validating the fledgling biotech’s neurology strategy. The company was launched by a pair of...

Oct 13 2026

Uncategorized

Scientists uncover a hidden map of the brain with 539 distinct regions

by Clinical Editor

No Comments

Scientists have uncovered a hidden layer of organization in the brain by creating the first detailed 3D map of its lipids, the fatty molecules essential for brain structure and communication....

Oct 11 2026

Uncategorized

Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives – Fierce Pharma

by Clinical Editor

No Comments

Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives  Fierce Pharma

Oct 11 2026

Uncategorized

At 85, Pune father’s biggest worry: Who will care for daughter with schizophrenia? – The Indian Express

by Clinical Editor

No Comments

At 85, Pune father’s biggest worry: Who will care for daughter with schizophrenia?  The Indian Express

Oct 10 2026

Uncategorized

Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives

by Clinical Editor

No Comments

With a Friday go-ahead from the FDA, another key piece of Teva’s innovation revamp strategy has fallen into place, further bolstering the drugmaker’s footing in schizophrenia.  | With a Friday...

Oct 10 2026

Uncategorized

US FDA flags four deaths in Newron’s schizophrenia drug studies

by Clinical Editor

No Comments

Oct 8 (Reuters) – Italy’s Newron Pharmaceuticals said on Thursday the US FDA had identified four deaths among patients treated with its experimental schizophrenia drug in feedback following the agency...

Oct 09 2026

Uncategorized

Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold

by Clinical Editor

No Comments

After one patient death prompted an FDA hold this spring, Newron Pharmaceuticals has now shared that a total of four fatalities have been recorded among participants receiving its schizophrenia …